EB-2 NIW Approval for a Medicinal Chemist / Biochemist in Protein Engineering

On March 27, 2025, we successfully secured another EB-2 NIW (National Interest Waiver) approval for a Chemist/Biochemist (PhD) specializing in Protein Engineering without RFE.

General Field

Protein Engineering

Background

9 published papers (1 First Author)

141 citation

Case Details

Case Filed: May 28, 2024

Case Approved: March 27, 2025

Processed at: USCIS Texas Service Center

Case Summary

The applicant is pursuing a PhD’s degree in Medicinal and Pharmaceutical Chemistry, specializing in Protein Engineering. Her drug discovery and development is pivotal, providing crucial insights into the efficacy and safety profiles of pharmaceutical compounds. We highlighted the practical implications of her research, which ultimately led to her successful EB-2 NIW approval.